Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03853317
What this trial is testing

QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy

Who this might be right for
Merkel Cell Carcinoma
ImmunityBio, Inc. 9
Early research (Phase 1)WithdrawnNCT04955262
What this trial is testing

A CD8 Positron Emission Tomography With Computed Tomography (PET/CT) Study Using ⁸⁹Zr Df-IAB22M2C in Patients With Metastatic Melanoma Receiving Bempegaldesleukin (NKTR-214) and Nivolumab

Who this might be right for
Metastatic Melanoma
Nektar Therapeutics
Not applicableUnknownNCT02420600
What this trial is testing

The Clinical Relevance of Immune Cells and CTC in HNSCC Patients

Who this might be right for
RecurrenceMetastasisDeath
Chang Gung Memorial Hospital 300
Post-approval studies (Phase 4)UnknownNCT04038411
What this trial is testing

PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma

Who this might be right for
NK/T Cell Lymphoma
Mingzhi Zhang 50
Not applicableEnded earlyNCT01688284
What this trial is testing

The Role of Uterine NK Cells and T Cell Cytokines in Recurrent Miscarriage

Who this might be right for
Recurrent Pregnancy Losses
Woman's Health University Hospital, Egypt 500
Early research (Phase 1)Study completedNCT02890758
What this trial is testing

Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphoblastic Leukemia+11 more
Brenda Cooper, MD 14
Testing effectiveness (Phase 2)UnknownNCT04994210
What this trial is testing

Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL

Who this might be right for
Safety and Efficacy
Sun Yat-sen University 30
Early research (Phase 1)Study completedNCT02130869
What this trial is testing

A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas

Who this might be right for
NeuroblastomaLymphomaHigh-risk Tumor
St. Jude Children's Research Hospital 8
Large-scale testing (Phase 3)Study completedNCT03336086
What this trial is testing

Effect of Weight Reduction on Immunity

Who this might be right for
LymphocytesWeight LossViral Diseases+2 more
Shiraz University of Medical Sciences 29
Not applicableEnded earlyNCT02145039
What this trial is testing

Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases

Who this might be right for
Acute LeukemiasBurkitt's LymphomaChronic Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 2
Early research (Phase 1)Study completedNCT05182073
What this trial is testing

FT576 in Subjects With Multiple Myeloma

Who this might be right for
Multiple MyelomaMyeloma
Fate Therapeutics 31
Testing effectiveness (Phase 2)WithdrawnNCT03003728
What this trial is testing

2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)

Who this might be right for
Multiple Myeloma
University of Arkansas
Not applicableLooking for participantsNCT06848582
What this trial is testing

Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study

Who this might be right for
Soft Tissue Sarcoma (STS)
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05020015
What this trial is testing

TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Takeda 27
Testing effectiveness (Phase 2)UnknownNCT01933282
What this trial is testing

MESA Treatment for NK/T Cell Lymphoma

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Air Force Military Medical University, China 100
Early research (Phase 1)Active Not RecruitingNCT05020678
What this trial is testing

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

Who this might be right for
Lymphoma, Non-HodgkinB-cell Acute Lymphoblastic LeukemiaLarge B-cell Lymphoma+7 more
Nkarta, Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT07598955
What this trial is testing

Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma

Who this might be right for
B2 ThymomaThymic Carcinoma
Beijing Biotech 36
Early research (Phase 1)Study completedNCT06040918
What this trial is testing

Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis

Who this might be right for
Healthy Subjects
ImmunityBio, Inc. 10
Testing effectiveness (Phase 2)Looking for participantsNCT07256210
What this trial is testing

Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic T-cell LeukemiaMixed Phenotype Acute Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Early research (Phase 1)Active Not RecruitingNCT02573896
What this trial is testing

Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 13
Next Page